Incinta Medical Group Secures Tens of Millions in Series A Funding to Build a Client-Centric Global Assisted Reproductive Healthcare Network

Recently, Yunshida Medical Group, a company specializing in assisted reproductive medical services, completed a Series A financing round of tens of millions of US dollars. The investment was led by Alpha USD Fund in conjunction with other institutional investors, with Haoyue Capital serving as the exclusive financial advisor.

The assisted reproductive technology (ART) sector has garnered significant attention in recent years. According to a report by Frost & Sullivan, there were approximately 47.7 million infertile couples in China in 2017, of whom only about 527,000 received ART services. Due to the relaxation of China’s two-child policy and the stringent entry barriers for ART institutions, the domestic ART service market is expected to remain supply-constrained, with demand outstripping supply for the foreseeable future.

Not only in China, but globally, as living standards continue to rise and reproductive concepts evolve, childbirth is no longer solely a medical issue but is increasingly extending into the realm of premium consumption. Worldwide consumer demand for assisted reproductive technology (ART) is shifting from merely addressing infertility to optimizing eugenics and healthy child-rearing. Consequently, the ART market in China and around the world still holds substantial untapped potential, remaining a blue ocean opportunity.

Yunshida Medical Group was established in 2014. Since its inception, it has focused on the investment and operational management of assisted reproductive medicine both domestically and internationally, emerging as a dark horse in the industry in recent years. Aligning with the trends of market transformation and enhancement in the assisted reproductive medical sector, Yunshida Group has adopted a "customer-centric" core philosophy. Committed to meeting the diverse needs of patients and consumers, the group integrates domestic and international experts to build a multi-tiered and diversified medical service system. Currently, its medical service institutions are distributed across three major regions: China, Southeast Asia, and North America, initially forming a globalized medical service system characterized by comprehensive layout and synergistic complementarity.

Guided by this precise positioning, Yunshida Group has achieved rapid growth within just a few years. It has pioneered the establishment of expert studios and high-end clinics in China, represented by the He Fangfang Studio, to build a premium brand image for top-tier experts. This strategy has created a driving effect, fostering extensive and in-depth collaborations with primary-care hospitals to achieve mutual benefits and win-win outcomes.

In Southeast Asian countries such as Cambodia, independently operated reproductive medical centers leveraging Yunshida’s management expertise meet the comprehensive needs of patients from China and Southeast Asia through diagnostic and treatment standards on par with those in the United States, coupled with attentive, personalized care. The North American Reproductive Medical Centers under the Yunshida Group have ranked among the top nationwide for pregnancy success rates in advanced-age groups for two consecutive years, according to authoritative data from the U.S. Centers for Disease Control and Prevention (CDC).

A new reproductive medicine center to be established in North America is scheduled to open in the second half of the year. Positioned as Yunshida Group’s overseas flagship facility, the center embodies the group’s operational philosophy and brings together top-tier physicians and R&D expertise in North America. It will become a premier reproductive medicine center and R&D training hub in the region, offering state-of-the-art facilities, advanced technical capabilities, and a first-class service system, thereby setting a benchmark and demonstrating best practices for the industry’s future development.

Yunshida Group’s strategic presence in North America not only meets the healthcare service demands of mid-to-high-end clients worldwide but also strengthens the technical capabilities and training systems of its North American R&D center, thereby cultivating and supplying top-tier medical talent for Yunshida’s global healthcare system.

Following this round of financing, Yunda Group will continue to expand its network of medical institutions both in China and globally, further strengthening and expanding its global footprint to comprehensively meet consumers’ diverse needs in the field of assisted reproduction, thereby progressively achieving its established strategic development goals.

Dr. Shi Xiaoming, Chairman of Yunshida Group, brings a proven track record in corporate operations and a forward-looking strategic vision. As a former client and beneficiary of assisted reproductive technology (ART) services, she possesses a deep, empathetic understanding of every patient’s needs. She stated, “Assisted reproductive medicine is an industry that benefits humanity. It demands practitioners to exhibit resilient entrepreneurial spirit, a strong sense of social responsibility, as well as compassion and enthusiasm. Those solely driven by the pursuit of exorbitant profits should not enter this field. The sustainable development of healthcare institutions stems from accurate industry positioning and rational strategic layout on one hand, and reliable technical expertise coupled with high-quality, attentive service on the other. In providing ART services, we operate with empathy and warmth. While striving to assist every client and family, we also achieve our own growth. Witnessing each family experience the joy of parenthood through our efforts brings us immense happiness and fulfillment. We will continue to cultivate the ART industry with diligence and precision, avoiding blind conformity or trend-chasing. By conducting business with integrity and professionalism, we aim to build an ART ecosystem centered on customers, anchored by technology, and delivered through exceptional service.”